Mobirise Website Builder v4.11.6

Creating a Greater ImPaKT

New facility aligns top researchers, state-of-the-art tools to combat deadly pathogens

By Jason Winders

When you deal in the microscopically small, it can be difficult to open people’s eyes to the big picture.

“A facility like this is so necessary, it will advance new treatments and new vaccines that we desperately need,” explained Microbiology and Immunology Professor Eric Arts, PhD.

“What we will be able to do here – in Canada, in London, at Western – has the potential to revolutionize medicine.”

That work will originate out of the new Imaging Pathogens of Knowledge Translation (ImPaKT) Facility at the Schulich School of Medicine & Dentistry, a next-generation facility university officials see as essential toward its efforts to become a leader in infectious diseases research and to save lives.

The expected results? Nothing short of groundbreaking research discoveries. Nothing but innovative interdisciplinary collaborations.

Nothing less ambitious than saving or improving millions of lives through cures and treatments for some of the world’s most troubling human illnesses.

“What we will be able to do here – in Canada, in London, at Western – has the potential to revolutionize medicine.”
- Eric Arts, PhD


– Richard Gibson, Director, ImPaKT Facility